Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy.
Matteo LambertiniShona FieldingSibylle LoiblWolfgang JanniEmma ClarkMaria Alice FranzoiDebora FumagalliCarmela CaballeroLuca AreccoSharon SalomoniNoam F PondeFrancesca PoggioHee Jeong KimCynthia Villarreal-GarzaOlivia PaganiShani Paluch-ShimonAlberto BallestreroLucia Del MastroMartine PiccartJose BinesAnn H PartridgeEvandro de AzambujaPublished in: Journal of the National Cancer Institute (2022)
In patients with HER2-positive early BC treated with modern anticancer therapies, young age did not demonstrate either prognostic or predictive value, irrespective of hormone receptor status.
Keyphrases